COVID rebound after nirmatrelvir/ritonavir

Appears 2×

Teaching point

Symptomatic mild COVID rebound after a completed course of nirmatrelvir/ritonavir is managed supportively (paracetamol/ibuprofen) rather than repeating antivirals. Asymptomatic PCR positivity needs no extra treatment.

🔒 This is premium content

Unlock the teaching point, every stem variant and the answer keys for all specialties with a subscription.